Quantbot Technologies LP Morphic Holding, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$21.33 - $59.42 $127,979 - $356,520	6,000 New	6,000 $137,000
Q2 2022 Aug 09, 2022	SELL	$19.74 - $43.01 $5,921 - $12,903	-300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $9,570 - $13,733	264 Added 733.33%	300 $12,000
Q4 2021 Feb 11, 2022	SELL	$43.27 - $65.72 $34,616 - $52,576	-800 Reduced 95.69%	36 $1,000
Q3 2021 Nov 09, 2021	SELL	$53.61 - $67.5 $8,792 - $11,070	-164 Reduced 16.4%	836 $47,000
Q2 2021 Aug 12, 2021	BUY	$45.13 - $64.99 $45,130 - $64,989	1,000 New	1,000 $57,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.